April 11, 2012

Zoledronate Protects HIV Positive Men against Bone Loss for at Least 5 Years

This is groundbreaking  Two doses sustain increases in bone density past 5 years (plus calcium and vitamin D) http://www.hivandhepatitis.com/hiv-related-conditions/hiv-bone-loss-osteoporosis/3542-zoledronate-protects-hiv-positive-men-against-bone-loss-for-at-least-5-years
April 10, 2012

Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients

What You Don’t Know, You Can Selltagline Spring 2012<http://www.treatmentactiongroup.org/tagline/2012/spring/tagline/2012/spring>by Tracy SwanIn places where access to antiretroviral therapy is widespread, peopleliving with HIV are now dying from […]
April 4, 2012

Interleukin-7 is Looking Better and Better….

CROI 2012- Oral Presentation  #94:   Gut Mucosa T Lymphocyte Restoration in Chronically HIV+ Patients Treated with Recombinant Interleukin-7 HIV infection caused decreases in CD4 cells in […]
April 4, 2012

A friendlier Tenofovir-like Drug?

GS-7340 : Tenofovir Prodrug Requires Lower Doses, But Will It Be Friendlier on Kidney and Bones? CROI 2012- Oral Presentation  #103. GS-7340 25 mg and 40 […]